Primacy of hepatic insulin resistance in the development of the metabolic syndrome induced by an isocaloric moderate-fat diet in the dog - PubMed (original) (raw)
Primacy of hepatic insulin resistance in the development of the metabolic syndrome induced by an isocaloric moderate-fat diet in the dog
Stella P Kim et al. Diabetes. 2003 Oct.
Abstract
Obesity is highly correlated with insulin resistance and the development of type 2 diabetes. Insulin resistance will result in a decrease in insulin's ability to stimulate glucose uptake into peripheral tissue and will suppress glucose production by the liver. However, the development of peripheral and hepatic insulin resistance relative to one another in the context of obesity-associated insulin resistance is not well understood. To examine this phenomena, we used the moderate fat-fed dog model, which has been shown to develop both subcutaneous and visceral adiposity and severe insulin resistance. Six normal dogs were fed an isocaloric diet with a modest increase in fat content for 12 weeks, and they were assessed at weeks 0, 6, and 12 for changes in insulin sensitivity and glucose turnover. By week 12 of the diet, there was a more than twofold increase in trunk adiposity as assessed by magnetic resonance imaging because of an accumulation in both subcutaneous and visceral fat depots with very little change in body weight. Fasting plasma insulin had increased by week 6 (150% of week 0) and remained increased up to week 12 of the study (170% of week 0). Surprisingly, there appeared to be no change in the rates of insulin-stimulated glucose uptake as measured by euglycemic-hyperinsulinemic clamps throughout the course of fat feeding. However, there was an increase in steady-state plasma insulin levels at weeks 6 and 12, indicating a moderate degree of peripheral insulin resistance. In contrast to the moderate defect seen in the periphery, there was a marked impairment in insulin's ability to suppress endogenous glucose production during the clamp such that by week 12 of the study, there was a complete inability of insulin to suppress glucose production. Our results indicate that a diet enriched with a moderate amount of fat results in the development of both subcutaneous and visceral adiposity, hyperinsulinemia, and a modest degree of peripheral insulin resistance. However, there is a complete inability of insulin to suppress hepatic glucose production during the clamp, suggesting that insulin resistance of the liver may be the primary defect in the development of insulin resistance associated with obesity.
Similar articles
- Beta-cell "rest" accompanies reduced first-pass hepatic insulin extraction in the insulin-resistant, fat-fed canine model.
Kim SP, Ellmerer M, Kirkman EL, Bergman RN. Kim SP, et al. Am J Physiol Endocrinol Metab. 2007 Jun;292(6):E1581-9. doi: 10.1152/ajpendo.00351.2006. Epub 2007 Feb 6. Am J Physiol Endocrinol Metab. 2007. PMID: 17284579 - CB(1) antagonism restores hepatic insulin sensitivity without normalization of adiposity in diet-induced obese dogs.
Kim SP, Woolcott OO, Hsu IR, Stefanoski D, Harrison LN, Zheng D, Lottati M, Kolka C, Catalano KJ, Chiu JD, Kabir M, Ionut V, Bergman RN, Richey JM. Kim SP, et al. Am J Physiol Endocrinol Metab. 2012 May 1;302(10):E1261-8. doi: 10.1152/ajpendo.00496.2011. Epub 2012 Feb 28. Am J Physiol Endocrinol Metab. 2012. PMID: 22374758 Free PMC article. - Reduced access to insulin-sensitive tissues in dogs with obesity secondary to increased fat intake.
Ellmerer M, Hamilton-Wessler M, Kim SP, Huecking K, Kirkman E, Chiu J, Richey J, Bergman RN. Ellmerer M, et al. Diabetes. 2006 Jun;55(6):1769-75. doi: 10.2337/db05-1509. Diabetes. 2006. PMID: 16731841 - Central role of the adipocyte in the metabolic syndrome.
Bergman RN, Van Citters GW, Mittelman SD, Dea MK, Hamilton-Wessler M, Kim SP, Ellmerer M. Bergman RN, et al. J Investig Med. 2001 Jan;49(1):119-26. doi: 10.2310/6650.2001.34108. J Investig Med. 2001. PMID: 11217141 Review. - Non-esterified fatty acids and the liver: why is insulin secreted into the portal vein?
Bergman RN. Bergman RN. Diabetologia. 2000 Jul;43(7):946-52. doi: 10.1007/s001250051474. Diabetologia. 2000. PMID: 10952470 Review.
Cited by
- Epigenetics of Hepatic Insulin Resistance.
Maude H, Sanchez-Cabanillas C, Cebola I. Maude H, et al. Front Endocrinol (Lausanne). 2021 May 11;12:681356. doi: 10.3389/fendo.2021.681356. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34046015 Free PMC article. Review. - Fructose: it's "alcohol without the buzz".
Lustig RH. Lustig RH. Adv Nutr. 2013 Mar 1;4(2):226-35. doi: 10.3945/an.112.002998. Adv Nutr. 2013. PMID: 23493539 Free PMC article. - Portal glucose infusion-glucose clamp measures hepatic influence on postprandial systemic glucose appearance as well as whole body glucose disposal.
Zheng D, Ionut V, Mooradian V, Stefanovski D, Bergman RN. Zheng D, et al. Am J Physiol Endocrinol Metab. 2010 Feb;298(2):E346-53. doi: 10.1152/ajpendo.00280.2009. Epub 2009 Nov 24. Am J Physiol Endocrinol Metab. 2010. PMID: 19934401 Free PMC article. - Storage and Utilization of Glycogen by Mouse Liver during Adaptation to Nutritional Changes Are GLP-1 and PASK Dependent.
Pérez-García A, Hurtado-Carneiro V, Herrero-De-Dios C, Dongil P, García-Mauriño JE, Sánchez MD, Sanz C, Álvarez E. Pérez-García A, et al. Nutrients. 2021 Jul 26;13(8):2552. doi: 10.3390/nu13082552. Nutrients. 2021. PMID: 34444712 Free PMC article. - Impact of short-term high-fat feeding on glucose and insulin metabolism in young healthy men.
Brøns C, Jensen CB, Storgaard H, Hiscock NJ, White A, Appel JS, Jacobsen S, Nilsson E, Larsen CM, Astrup A, Quistorff B, Vaag A. Brøns C, et al. J Physiol. 2009 May 15;587(Pt 10):2387-97. doi: 10.1113/jphysiol.2009.169078. Epub 2009 Mar 30. J Physiol. 2009. PMID: 19332493 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical